Literature DB >> 28273554

Head drop after botox: Electrodiagnostic evaluation of iatrogenic botulinum toxicity.

Eliza Szuch1, James B Caress1, Bandhu Paudyal1, Allison Brashear1, Michael S Cartwright1, Roy E Strowd2.   

Abstract

BACKGROUND: Botulinum is a potent neurotoxin with increasing indications for neurologic disorders. While clinical benefit manifests primarily due to local actions at the neuromuscular junction, regional and systemic effects do occur. Rarely, systemic symptoms including weakness, dysarthria, dysphagia and other side effects occur as a result of iatrogenic botulinum neurotoxicity. CASE: A 72 year-old female with right leg dystonia developed head drop, bulbar and systemic weakness following right lower extremity botulinum toxin injection. Routine nerve conduction studies were normal. Repetitive stimulation of the spinal accessory nerve showed decrement; electromyography (EMG) demonstrated slightly small units with subtle signs of denervation, and single fiber EMG revealed increased jitter with blocking, all of which are consistent with systemic botulism.
CONCLUSION: This case highlights and reviews the important electrodiagnostic features of iatrogenic systemic botulinum neurotoxicity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adverse event; Botulinum toxin; Electrodiagnosis; Generalized weakness; Head drop

Mesh:

Substances:

Year:  2017        PMID: 28273554     DOI: 10.1016/j.clineuro.2017.02.012

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Longitudinal neurophysiological assessment of intramuscular type-A botulin toxin in healthy humans.

Authors:  L Lispi; L Leonardi; A Petrucci
Journal:  Neurol Sci       Date:  2017-11-11       Impact factor: 3.307

Review 2.  Contribution of Single-Fiber Evaluation on Monitoring Outcomes Following Injection of Botulinum Toxin-A: A Narrative Review of the Literature.

Authors:  Hélène Moron; Corine Gagnard-Landra; David Guiraud; Arnaud Dupeyron
Journal:  Toxins (Basel)       Date:  2021-05-17       Impact factor: 4.546

3.  Bulbar Muscle Weakness in the Setting of Therapeutic Botulinum Injections.

Authors:  Jacob Lentz; Daniel Weingrow
Journal:  Clin Pract Cases Emerg Med       Date:  2018-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.